Global Cord Stem Cell Banking Market Size, Trends and Growth Opportunity, By Storage Type (Private Banks, Hybrid Banks, Public Banks), By Product Type (Cord Blood, Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Region and forecast till 2027.
Global Cord Stem Cell Banking Market 
Global Cord Stem Cell Banking Market is valued at USD 8.3 billion in 2021 and is slated to reach at USD 36.30 billion by 2027 at a CAGR of 18.73% from 2022-2027.
The cord blood cells present in a newborn child's umbilical cord and placenta are kept in storage through cord stem cell banking. This cord blood contains stem cells that may one day be extensively employed to treat conditions including thalassemia, autoimmune disorders, leukaemia, and hereditary metabolic problems, among others.
Market Drivers
A growing trend in the market for cord stem cell banking has been observed recently, combining the storage of cord blood and tissue with genetic testing services. Due to the complementary services it provides to the company's current clients, this pairing is effective and makes it possible for them to expand their product line. For example, Natera, a company that provides genetic testing, recently introduced the Evercord cord blood and tissue storage service, which enables expectant parents to collect, store, and retrieve cord blood from newborns as well as tissue for use in transplantation and regenerative medicine applications. Because of this, market growth will be boosted. In the United Kingdom, there were approximately 457,960 new instances of cancer, with skin, lung, colon, and prostate cancer being the most often found varieties. The same source reports that there were 415,269 new cancer cases and approximately 174,759 deaths in Italy. Cancers including leukaemia and multiple myeloma can be successfully treated with stem cell transplantation. The blood-forming stem cells that chemotherapy injured can be repaired utilising stem cells. Cord stem cell banking is therefore widely employed in research institutions and hospitals as a result of the rising number of cancer patients, and it is also expected to increase dramatically throughout the course of the projection period.
Regulatory agencies and non-governmental organisations (NGOs) are launching a number of campaigns to educate consumers about the therapeutic potential of stem cells, which will have an impact on the growth of the stem cell banking industry. These campaigns are being conducted in both developed and developing regions. Section 212 of the Small Business Regulatory Enforcement Fairness Act provides guidelines for cord stem cell banking to the U.S. FDA. According to this law, the FDA is in charge of overseeing the distribution of cord blood stem cells for unrelated allogeneic usage, and distributors must obtain a licence from the FDA in order to sell these goods. The manufacturing and storage conditions are examined by the FDA before issuing these licences. This contributes to the market's growth by stimulating it.
Market Restraints
The market is severely constrained by lack of awareness, particularly among pregnant women. This is mostly due to the fact that few pregnant women are aware of how public cord blood banks operate. The benefits of stem cell transplantation for cancer treatment mean that this alternative is not well understood and utilised. This constrains market expansion as a result.
Recent Development
A collaborative agreement for stem cell study and development was signed in 2021 by BioTherapeutic Laboratories Corp. and American CryoStem. BTL will market the products and services of CRYO. In order to develop protocols using BTL's human umbilical cord-based product lines and CRYO's ATCell autologous mesenchymal stem cells, the two businesses will work together.
Market Segmentation
Global Cord Stem Cell Banking Market is segmented into Storage Type, Product Type, Service Type, Source and Indication. By storage Type such as Private Banks, Hybrid Banks, Public Banks. By Product Type such as Cord Blood, Cord Tissue. By Service Type such as Collection & Transportation, Processing, Analysis, Storage. By Source such as Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood. By Indication such as Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism.
Regional Analysis
Global Cord Stem Cell Banking Market is segmented into five regions Americas, Europe, Asia-Pacific, and the Middle East & Africa. North America now holds a dominant position in the cord stem cell banking market as a result of an expansion in the number of significant market participants in the U.S., continued approval of stem cell lines for the treatment of disease, and rising public awareness in this area. A rise in the older population, an uptick in the prevalence of chronic diseases, and rising per capita healthcare costs in the Asia-Pacific area are all predicted to contribute to the region's major growth. Moreover, market expansion is being aided by the region's expanding healthcare infrastructure.
Key Players
This report includes a list of numerous Key Players, namely CBR Systems, Inc., (U.S.), Cordlife (Singapore), Cryo-Cell International, Inc., (U.S.), ViaCord (U.S.), Cryo-Save (Netherlands), LifeCell International Pvt. Ltd.  (India), StemCyte India Therapeutics Pvt. Ltd (U.S.), Global Cord Blood Corporation (China), Smart Cells International Limited (U.K.), BrainStorm Cell Limited (U.S.).
Market Taxonomy
By Storage Type
•        Private Banks
•        Hybrid Banks
•        Public Banks
By Product Type
•        Cord Blood
•        Cord Tissue
By Service Type
•        Collection & Transportation
•        Processing
•        Analysis
•        Storage
By Source
•        Umbilical Cord Blood
•        Bone Marrow
•        Peripheral Blood Stem
•        Menstrual Blood
By Indication
•        Cerebral Palsy
•        Thalassemia
•        Leukemia
•        Diabetes
•        Autism
By Region
•        North America
•        Latin America
•        Europe
•        Asia Pacific
•        Middle East & Africa.
 

Global Cord Stem Cell Banking Market
1 Introduction        
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Cord Stem Cell Banking Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Cord Stem Cell Banking Market, By Storage Type
5.1 Y-o-Y Growth Comparison, By Storage Type
5.2 Global Cord Stem Cell Banking Market Share Analysis, By Storage Type
5.3 Global Cord Stem Cell Banking Market Size and Forecast, By Storage Type
5.3.1 Private Banks
5.3.2 Hybrid Banks
5.3.3 Public Banks 
6 Global Cord Stem Cell Banking Market, By Product Type
6.1 Y-o-Y Growth Comparison, By Product Type
6.2 Global Cord Stem Cell Banking Market Share Analysis, By Product Type
6.3 Global Cord Stem Cell Banking Market Size and Forecast, By Product Type
6.3.1 Cord Blood
6.3.2 Cord Tissue
7 Global Cord Stem Cell Banking Market, By Service Type
7.1 Y-o-Y Growth Comparison, By Service Type
7.2 Global Cord Stem Cell Banking Market Share Analysis, By Service Type
7.3 Global Cord Stem Cell Banking Market Size and Forecast, By Service Type
7.3.1 Collection & Transportation
7.3.2 Processing
7.3.3 Analysis
7.3.4 Storage. 
8 Global Cord Stem Cell Banking Market, By Source
8.1 Y-o-Y Growth Comparison, By Source
8.2 Global Cord Stem Cell Banking Market Share Analysis, By Source
8.3 Global Cord Stem Cell Banking Market Size and Forecast, By Source 
8.3.1 Umbilical Cord Blood
8.3.2 Bone Marrow
8.3.3 Peripheral Blood Stem
8.3.4 Menstrual Blood
9 Global Cord Stem Cell Banking Market, By Indication
9.1 Y-o-Y Growth Comparison, By Indication
9.2 Global Cord Stem Cell Banking Market Share Analysis, By Indication
9.3 Global Cord Stem Cell Banking Market Size and Forecast, By Indication
9.3.1 Cerebral Palsy
9.3.2 Thalassemia
9.3.3 Leukemia
9.3.4 Diabetes
9.3.5 Autism
10 Global Cord Stem Cell Banking Market, By Region
10.1 Global Cord Stem Cell Banking Market Share Analysis, By Region
10.2 Global Cord Stem Cell Banking Market Share Analysis, By Region
10.3 Global Cord Stem Cell Banking Market Size and Forecast, By Region
11 North America Cord Stem Cell Banking Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 North America Cord Stem Cell Banking Market Share Analysis, By Storage Type
11.3 North America Cord Stem Cell Banking Market Size and Forecast, By Product Type
11.4 North America Cord Stem Cell Banking Market Size and Forecast, By Service Type
11.5 North America Cord Stem Cell Banking Market Size and Forecast, By Source
11.6 North America Cord Stem Cell Banking Market Size and Forecast, By Indication
11.7 North America Cord Stem Cell Banking Market Size and Forecast, By Country
11.7.1 U.S.
11.7.2 Canada
11.7.3 Mexico
12 Europe Cord Stem Cell Banking Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Europe Cord Stem Cell Banking Market Share Analysis, By Storage Type
12.3 Europe Cord Stem Cell Banking Market Size and Forecast, By Product Type 
12.4 Europe Cord Stem Cell Banking Market Size and Forecast, By Service Type
12.5 Europe Cord Stem Cell Banking Market Size and Forecast, By Source
12.6 Europe Cord Stem Cell Banking Market Size and Forecast, By Indication
12.7 Europe Cord Stem Cell Banking Market Size and Forecast, By Country
12.7.1 Germany
12.7.2 France
11.7.3 UK
11.7.4 Rest of Europe
13 Asia Pacific Cord Stem Cell Banking Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Asia Pacific Cord Stem Cell Banking Market Share Analysis, By Storage Type
13.3 Asia Pacific Cord Stem Cell Banking Market Size and Forecast, By Product Type 
13.4 Asia Pacific Cord Stem Cell Banking Market Size and Forecast, By Service Type
13.5 Asia Pacific Cord Stem Cell Banking Market Size and Forecast, By Source
13.6 Asia Pacific Cord Stem Cell Banking Market Size and Forecast, By Indication
13.7 Asia Pacific Cord Stem Cell Banking Market Size and Forecast, By Country
13.7.1 China        
13.7.2 Japan
13.7.3 India
13.7.4 Rest of Asia Pacific
14 Latin America Cord Stem Cell Banking Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Latin America Cord Stem Cell Banking Market Share Analysis, By Storage Type
14.3 Latin America Cord Stem Cell Banking Market Size and Forecast, By Product Type 
14.4 Latin America Cord Stem Cell Banking Market Size and Forecast, By Service Type
14.5 Latin America Cord Stem Cell Banking Market Size and Forecast, By Source
14.6 Latin America Cord Stem Cell Banking Market Size and Forecast, By Indication
14.7 Latin America Cord Stem Cell Banking Market Size and Forecast, Country
14.7.1 Brazil
14.7.2 Rest of Latin America
15 Middle East Cord Stem Cell Banking Market Analysis and Forecast (2022-2027)
15.1 Introduction
15.2 Middle East Cord Stem Cell Banking Market Share Analysis, By Storage Type
15.3 Middle East Cord Stem Cell Banking Market Size and Forecast, By Product Type 
15.4 Middle East Cord Stem Cell Banking Market Size and Forecast, By Service Type
15.5 Middle East Cord Stem Cell Banking Market Size and Forecast, By Source
15.6 Middle East Cord Stem Cell Banking Market Size and Forecast, By Indication
15.7 Middle East Cord Stem Cell Banking Market Size and Forecast, By Country
15.7.1 Saudi Arabia
15.7.2 UAE
15.7.3 Egypt
15.7.4 Kuwait
15.7.5 South Africa
16 Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17 Company Profiles
17.1 CBR Systems, Inc. (U.S.) 
17.1.1 Overview
17.1.2 Offerings
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2 Cordlife (Singapore)  
17.2.1 Overview
17.2.2 Offerings
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3 Cryo-Cell International, Inc., (U.S.) 
17.3.1 Overview
17.3.2 Offerings
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 ViaCord (U.S.)
17.4.1 Overview
17.4.2 Offerings
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
17.4.6 Key Strategies
17.5 Cryo-Save (Netherlands)
17.5.1 Overview
17.5.2 Offerings
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 LifeCell International Pvt. Ltd.  (India) 
17.6.1 Overview
17.6.2 Offerings
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 StemCyte India Therapeutics Pvt. Ltd (U.S.) 
17.7.1 Overview
17.7.2 Offerings
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies        
17.8 Global Cord Blood Corporation (China) 
17.8.1 Overview
17.8.2 Offerings
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 Smart Cells International Limited (U.K.) 
17.9.1 Overview
17.9.2 Offerings
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
17.10 BrainStorm Cell Limited (U.S.)
17.10.1 Overview
17.10.2 Offerings
17.10.3 Key Financials
17.10.4 Business Segment & Geographic Overview
17.10.5 Key Market Developments
17.10.6 Key Strategies